Catholic University of Korea Researcher Targets Cancer (Abstract 6757: Identification of predictive factors for early relapse in patients with unresectable stage III NSCLC receiving consolidation durvalumab after concurrent chemoradiation)

Press/Media

Period26 Apr 2023

Media coverage

1

Media coverage